230 related articles for article (PubMed ID: 33341898)
21. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
22. A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis.
Dorajoo SR; Tan WJ; Koo SX; Tan WS; Chew MH; Tang CL; Wee HL; Yap CW
Int J Colorectal Dis; 2016 Feb; 31(2):235-45. PubMed ID: 26490055
[TBL] [Abstract][Full Text] [Related]
23. Serum C-Reactive Protein-to-Body Mass Index Ratio Predicts Overall Survival in Patients With Resected Colorectal Cancer.
Huang L; Liu J; Huang X; Wei C; Mo X; Zhong H; Meng Y; Lai H; Zhang L; Liang D; Liu H; Tang W
Technol Cancer Res Treat; 2021; 20():15330338211037418. PubMed ID: 34338056
[TBL] [Abstract][Full Text] [Related]
24. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
25. Forty-Two Years' Experience with Pulmonary Resections of Metastases from Colorectal Cancer.
Dudek W; Schreiner W; Hohenberger W; Klein P; Sirbu H
Thorac Cardiovasc Surg; 2017 Oct; 65(7):560-566. PubMed ID: 26962969
[No Abstract] [Full Text] [Related]
26. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
[TBL] [Abstract][Full Text] [Related]
27. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival.
Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D
PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523
[TBL] [Abstract][Full Text] [Related]
28. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
[TBL] [Abstract][Full Text] [Related]
29. Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials.
Faron M; Pignon JP; Malka D; Bourredjem A; Douillard JY; Adenis A; Elias D; Bouché O; Ducreux M
Eur J Cancer; 2015 Jan; 51(2):166-76. PubMed ID: 25465185
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis.
Fernández Montes A; López López C; Argilés Martínez G; Páez López D; López Muñoz AM; García Paredes B; Gutiérrez Abad D; Castañón López C; Jiménez Fonseca P; Gallego Plazas J; López Doldán MC; Martínez de Castro E; Sánchez Cánovas M; Tobeña Puyal M; Llorente Ayala B; Juez Martel I; López Flores M; Carmona-Bayonas A
Oncologist; 2019 Aug; 24(8):e687-e695. PubMed ID: 31147489
[TBL] [Abstract][Full Text] [Related]
31. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
[TBL] [Abstract][Full Text] [Related]
32. Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer.
Quidde J; Denne L; Kutscheidt A; Kindler M; Kirsch A; Kripp M; Petersen V; Schulze M; Seraphin J; Tummes D; Arnold D; Stein A
Oncol Res Treat; 2017; 40(1-2):21-26. PubMed ID: 28192780
[TBL] [Abstract][Full Text] [Related]
33. The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy.
Sunaga T; Suzuki S; Kogo M; Kurihara T; Kaji S; Koike N; Harada N; Suzuki M; Kiuchi Y
Eur J Cancer Care (Engl); 2014 May; 23(3):394-400. PubMed ID: 24033646
[TBL] [Abstract][Full Text] [Related]
34. The Number of Risk Factors Determines the Outcome Of Stage II Colorectal Cancer Patients.
Lin HH; Yang HL; Lin JK; Lin CC; Wang HS; Yang SH; Jiang JK; Lan YT; Lin TC; Chen WS; Liang WY; Chang SC
Hepatogastroenterology; 2014 Jun; 61(132):1024-7. PubMed ID: 26158160
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in survival of colorectal cancer patients after surgery.
Mehrkhani F; Nasiri S; Donboli K; Meysamie A; Hedayat A
Colorectal Dis; 2009 Feb; 11(2):157-61. PubMed ID: 18462239
[TBL] [Abstract][Full Text] [Related]
36. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
[TBL] [Abstract][Full Text] [Related]
37. Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma.
Hugen N; Verhoeven RH; Radema SA; de Hingh IH; Pruijt JF; Nagtegaal ID; Lemmens VE; de Wilt JH
Ann Oncol; 2013 Nov; 24(11):2819-24. PubMed ID: 24057984
[TBL] [Abstract][Full Text] [Related]
38. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.
Razenberg LG; van Gestel YR; Lemmens VE; de Wilt JH; Creemers GJ; de Hingh IH
Clin Colorectal Cancer; 2015 Dec; 14(4):e13-9. PubMed ID: 26140733
[TBL] [Abstract][Full Text] [Related]
39. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
[TBL] [Abstract][Full Text] [Related]
40. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.
Franko J; Shi Q; Meyers JP; Maughan TS; Adams RA; Seymour MT; Saltz L; Punt CJA; Koopman M; Tournigand C; Tebbutt NC; Diaz-Rubio E; Souglakos J; Falcone A; Chibaudel B; Heinemann V; Moen J; De Gramont A; Sargent DJ; Grothey A;
Lancet Oncol; 2016 Dec; 17(12):1709-1719. PubMed ID: 27743922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]